Neuroinformatics tools for visualizing gene expression in the brain

Floyd E. Bloom, John Morrison, Jeff M. Redwine, John F. Reilly, Warren G. Young

Research output: Contribution to journalReview article

Abstract

Central nervous system diseases constitute a major target for drug development. Genes expressed by the nervous system may represent half or more of the mammalian genome, with literally tens of thousands of gene products. Better methods are therefore required to accelerate the pace of mapping gene expression patterns in the mouse brain and to evaluate the progressive phenotypic changes in genetic models of human brain diseases. Recent studies of mouse models of amyotrophic lateral sclerosis and Alzheimer's disease illustrate how such data could be used for drug development.

Original languageEnglish (US)
Pages (from-to)112-119
Number of pages8
JournalDrug Discovery Today: BIOSILICO
Volume2
Issue number3
DOIs
StatePublished - May 1 2004
Externally publishedYes

Fingerprint

Gene Expression
Central Nervous System Diseases
Genetic Models
Amyotrophic Lateral Sclerosis
Brain
Brain Diseases
Pharmaceutical Preparations
Nervous System
Genes
Alzheimer Disease
Genome

ASJC Scopus subject areas

  • Drug Discovery

Cite this

Neuroinformatics tools for visualizing gene expression in the brain. / Bloom, Floyd E.; Morrison, John; Redwine, Jeff M.; Reilly, John F.; Young, Warren G.

In: Drug Discovery Today: BIOSILICO, Vol. 2, No. 3, 01.05.2004, p. 112-119.

Research output: Contribution to journalReview article

Bloom, Floyd E. ; Morrison, John ; Redwine, Jeff M. ; Reilly, John F. ; Young, Warren G. / Neuroinformatics tools for visualizing gene expression in the brain. In: Drug Discovery Today: BIOSILICO. 2004 ; Vol. 2, No. 3. pp. 112-119.
@article{0ecc3d31440e4e96bc7dbd46fdc97636,
title = "Neuroinformatics tools for visualizing gene expression in the brain",
abstract = "Central nervous system diseases constitute a major target for drug development. Genes expressed by the nervous system may represent half or more of the mammalian genome, with literally tens of thousands of gene products. Better methods are therefore required to accelerate the pace of mapping gene expression patterns in the mouse brain and to evaluate the progressive phenotypic changes in genetic models of human brain diseases. Recent studies of mouse models of amyotrophic lateral sclerosis and Alzheimer's disease illustrate how such data could be used for drug development.",
author = "Bloom, {Floyd E.} and John Morrison and Redwine, {Jeff M.} and Reilly, {John F.} and Young, {Warren G.}",
year = "2004",
month = "5",
day = "1",
doi = "10.1016/S1741-8364(04)02400-X",
language = "English (US)",
volume = "2",
pages = "112--119",
journal = "Drug Discovery Today",
issn = "1359-6446",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - Neuroinformatics tools for visualizing gene expression in the brain

AU - Bloom, Floyd E.

AU - Morrison, John

AU - Redwine, Jeff M.

AU - Reilly, John F.

AU - Young, Warren G.

PY - 2004/5/1

Y1 - 2004/5/1

N2 - Central nervous system diseases constitute a major target for drug development. Genes expressed by the nervous system may represent half or more of the mammalian genome, with literally tens of thousands of gene products. Better methods are therefore required to accelerate the pace of mapping gene expression patterns in the mouse brain and to evaluate the progressive phenotypic changes in genetic models of human brain diseases. Recent studies of mouse models of amyotrophic lateral sclerosis and Alzheimer's disease illustrate how such data could be used for drug development.

AB - Central nervous system diseases constitute a major target for drug development. Genes expressed by the nervous system may represent half or more of the mammalian genome, with literally tens of thousands of gene products. Better methods are therefore required to accelerate the pace of mapping gene expression patterns in the mouse brain and to evaluate the progressive phenotypic changes in genetic models of human brain diseases. Recent studies of mouse models of amyotrophic lateral sclerosis and Alzheimer's disease illustrate how such data could be used for drug development.

UR - http://www.scopus.com/inward/record.url?scp=12444314034&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12444314034&partnerID=8YFLogxK

U2 - 10.1016/S1741-8364(04)02400-X

DO - 10.1016/S1741-8364(04)02400-X

M3 - Review article

AN - SCOPUS:12444314034

VL - 2

SP - 112

EP - 119

JO - Drug Discovery Today

JF - Drug Discovery Today

SN - 1359-6446

IS - 3

ER -